References
1. Marotto D, Sarzi-Puttini P. What is the role of rheumatologists in the era of COVID-19. Autoimmun Rev. 2020; 19(6):102539.
2. Stein R. COVID-19: risk groups, mechanistic insights, and challenges. Int J Clin Pract e13512. 2020 doi: 10.1111/ijcp.13512.
3. Annapureddy N, Nalleballe K, Onteddu SR, Sharma R, Sheng S, Kovvuru S, Siddamreddy S, Mandhadi R. Biologics in systemic autoimmune diseases during COVID-19 pandemic. Clin Rheumatol. 2020;4:1–3.
4. Yildiz M, Haslak F, Adrovic A, Sahin S, Barut K, Kasapcopur O. The frequency and clinical course of COVID-19 infection in children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2020 Oct 18. Epub ahead of print. PMID: 33124561.
5. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020; 79(5):667-668.